KalVista Pharmaceuticals News

KalVista Pharmaceuticals | 8-K: Current report

Apr 22 16:58 ET

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Fairey William

Apr 22 16:42 ET

KalVista Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Fairey William

Apr 22 16:38 ET

KalVista Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TCG Crossover GP I, LLC(3.2%),TCG Crossover Fund I, L.P.(3.2%), etc.

Apr 1 16:19 ET

KalVista Pharmaceuticals | 8-K: KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update

Mar 11 16:45 ET

KalVista Pharmaceuticals | 10-Q: Quarterly report

Mar 11 16:28 ET

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Palleiko Benjamin L

Mar 8 16:52 ET

KalVista Pharmaceuticals | 8-K: Current report

Mar 7 06:39 ET

KalVista Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adage Capital Partners, L.P.(6.87%),Adage Capital Partners GP, L.L.C.(6.87%), etc.

Feb 26 16:44 ET

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner Venrock Healthcare Capital Partners III, L.P.

Feb 22 16:17 ET

KalVista Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James N. Topper(8.9%),Patrick J. Heron(8.9%), etc.

Feb 22 13:27 ET

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Feener Edward P.

Feb 21 21:52 ET

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yea Christopher

Feb 21 21:52 ET

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Palleiko Benjamin L

Feb 21 21:52 ET

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Audhya Paul K.

Feb 21 21:47 ET

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Crockett Thomas Andrew

Feb 21 21:47 ET

KalVista Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TCG Crossover GP I, LLC(6.52%),TCG Crossover Fund I, L.P.(6.52%), etc.

Feb 20 16:54 ET

KalVista Pharmaceuticals | 8-K: Current report

Feb 16 16:40 ET

KalVista Pharmaceuticals | 424B5: Prospectus

Feb 16 16:32 ET

KalVista Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Yea Christopher

Feb 16 16:25 ET